You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 10,406,332


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,406,332 protect, and when does it expire?

Patent 10,406,332 protects SINUVA and is included in one NDA.

This patent has thirteen patent family members in seven countries.

Summary for Patent: 10,406,332
Title:Systems, devices, and method for treating a sinus condition
Abstract: Systems, devices, and methods may be used for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant.
Inventor(s): Abbate; Anthony J. (Santa Clara, CA)
Assignee: Intersect ENT, Inc. (Menlo Park, CA)
Application Number:14/210,078
Patent Claim Types:
see list of patent claims
Composition; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,406,332: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 10,406,332, it is crucial to delve into its scope, claims, and the broader patent landscape. This analysis will help in understanding the patent's validity, its position within the intellectual property ecosystem, and its potential impact on the market.

Patent Basics

What is a Patent?

A patent is a form of intellectual property that gives its owner the legal right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date of the patent application[4].

Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO ensures that patents are granted to inventions that meet the criteria of novelty, non-obviousness, and utility[2].

Patent 10,406,332 Overview

Patent Title and Abstract

To begin, it is essential to review the title and abstract of the patent to understand its general scope. The title provides a brief description of the invention, while the abstract offers a more detailed summary of the invention's purpose and key features.

Claims

The claims section of a patent is critical as it defines the scope of the invention. Claims are the legal boundaries of what the patent protects and are often the most contentious part of a patent during litigation. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Claim Analysis

Independent Claims

Independent claims are the broadest claims in a patent and define the invention in its most general form. These claims are crucial because they set the outer limits of what is protected by the patent.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims are often used to provide more specific examples of the invention and can help in defending the patent against challenges.

Patent Scope and Breadth

Understanding Patent Scope

The scope of a patent is determined by its claims. A broader scope means the patent covers a wider range of variations of the invention, while a narrower scope limits the protection to more specific embodiments. The Patent Claims Research Dataset by the USPTO can provide insights into how claims are structured and their dependency relationships, which can be useful in analyzing the scope of a patent[3].

Obviousness-Type Double Patenting (ODP)

Definition and Impact

Obviousness-Type Double Patenting (ODP) is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is obvious over a prior patent. This is particularly relevant when dealing with continuation-in-part patents or patents that have received Patent Term Adjustments (PTA)[1].

Case Example: In re Cellect

The case of In re Cellect highlights the complexities of ODP. Here, multiple patents from the same family were invalidated due to ODP, tracing back to a single family member patent that did not receive PTA. This case underscores the importance of considering the expiration dates and PTA when evaluating the validity of related patents[1].

Patent Term Adjustments (PTA) and Terminal Disclaimers

PTA and Its Effects

PTA is granted to compensate for delays in the patent prosecution process. However, as seen in In re Cellect, PTA does not extend the term of a patent past the date of a terminal disclaimer. This distinction is crucial when analyzing the effective term of a patent and its implications for ODP[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections by ensuring that the later-expiring patent does not extend beyond the term of the earlier-expiring patent. This mechanism helps in maintaining the integrity of the patent system by preventing the extension of patent terms through multiple related patents[1].

Patent Landscape and Market Impact

Competitive Analysis

Understanding the patent landscape involves identifying other patents in the same field and assessing how they interact with the patent in question. This analysis can reveal potential competitors, licensing opportunities, and areas for innovation.

Economic Impact

Patents can significantly impact the market by providing a monopoly on an invention, which can drive innovation but also limit competition. The economic research datasets provided by the USPTO can offer insights into the economic impact of patents and their scope[3].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This initiative, explored by the Administrative Conference of the United States (ACUS), aims to make patent enforcement more accessible to smaller entities[5].

Key Takeaways

  • Claims Analysis: The claims section is pivotal in defining the scope and breadth of a patent.
  • ODP Considerations: Understanding ODP is crucial to avoid invalidation of related patents.
  • PTA and Terminal Disclaimers: These mechanisms affect the effective term of a patent and its validity.
  • Patent Landscape: Analyzing the broader patent landscape helps in understanding competitive and market implications.
  • Legal and Policy: Initiatives like the small claims patent court can impact how patents are enforced.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope and boundaries of what the patent protects.

How does Obviousness-Type Double Patenting (ODP) affect patents?

ODP prevents an inventor from securing a second, later-expiring patent for an invention that is obvious over a prior patent, ensuring that the patent term is not extended unfairly.

What is the difference between Patent Term Adjustments (PTA) and Patent Term Extensions (PTE)?

PTA compensates for delays in the patent prosecution process but does not extend the term past the date of a terminal disclaimer, whereas PTE can extend the term of a patent under specific conditions.

Why is understanding the patent landscape important?

Understanding the patent landscape helps in identifying competitors, potential licensing opportunities, and areas for innovation, which is crucial for strategic business decisions.

What is the proposed small claims patent court intended to achieve?

The proposed small claims patent court aims to simplify and reduce the costs associated with patent litigation, making it more accessible to smaller entities.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent and Trademark Office (USPTO) - USAGov[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Patent Law in the United States - BitLaw[4].
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,406,332

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Intersect Ent Inc SINUVA mometasone furoate IMPLANT;IMPLANTATION 209310-001 Dec 8, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.